Corrigendum to: Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells (Journal of Cellular and Molecular Medicine, (2011), 15, 8, (1757-1768), 10.1111/j.1582-4934.2010.01166.x);Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 8, 2011, Pages 1757-1768

  Nyman, Ulrika ^a   Muppani, Naveen Reddy ^a   Zhivotovsky, Boris ^a   Joseph, Bertrand ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apoptosis; Bax; Hsp72; HSPA1A; Mitochondria; P73

Indexed keywords

EID: 79960302146     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.13094     Document Type: Erratum

References (53)

1. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997; 90: 809-19.
2. Jost CA, Marin MC, Kaelin WG Jr. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997; 389: 191-4.
3. De Laurenzi V, Raschella G, Barcaroli D, et al. Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem. 2000; 275: 15226-31.
4. Grob TJ, Novak U, Maisse C, et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 2001; 8: 1213-23.
5. Chi SG, Chang SG, Lee SJ, et al. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer. Cancer Res. 1999; 59: 2791-3.
6. Ishimoto O, Kawahara C, Enjo K, et al. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res. 2002; 62: 636-41.
7. Moll UM, Erster S, Zaika A. p53, p63 and p73-solos, alliances and feuds among family members. Biochim Biophys Acta. 2001; 1552: 47-59.
8. Stiewe T, Putzer BM. Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ. 2002; 9: 237-45.
9. Zitterbart K, Zavrelova I, Kadlecova J, et al. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival. Acta Neuropathol. 2007; 114: 641-50.
10. Novak U, Grob TJ, Baskaynak G, et al. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Ann Oncol. 2001; 12: 981-6.
11. Niyazi M, Ghazizadeh M, Konishi H, et al. Expression of p73 and c-Abl proteins in human ovarian carcinomas. J Nippon Med Sch. 2003; 70: 234-42.
12. Kang MJ, Park BJ, Byun DS, et al. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clin Cancer Res. 2000; 6: 1767-71.
13. Yokomizo A, Mai M, Tindall DJ, et al. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene. 1999; 18: 1629-33.
14. Frasca F, Vella V, Aloisi A, et al. p73 tumor-suppressor activity is impaired in human thyroid cancer. Cancer Res. 2003; 63: 5829-37.
15. Vikhanskaya F, Marchini S, Marabese M, et al. P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line. Cancer Res. 2001; 61: 935-8.
16. Nyman U, Sobczak-Pluta A, Vlachos P, et al. Full-length p73alpha represses drug-induced apoptosis in small cell lung carcinoma cells. J Biol Chem. 2005; 280: 34159-69.
17. Stankiewicz AR, Lachapelle G, Foo CP, et al. Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem. 2005; 280: 38729-39.
18. Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med. 2004; 200: 425-35.
19. Creagh EM, Carmody RJ, Cotter TG. Heat shock protein 70 inhibits caspase-dependent and -independent apoptosis in Jurkat T cells. Exp Cell Res. 2000; 257: 58-66.
20. Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001; 3: 839-43.
21. Mosser DD, Caron AW, Bourget L, et al. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol. 2000; 20: 7146-59.
22. Mosser DD, Caron AW, Bourget L, et al. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 1997; 17: 5317-27.
23. Tanaka Y, Kameoka M, Itaya A, et al. Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73alpha. Biochem Biophys Res Commun. 2004; 317: 865-72.
24. De Laurenzi V, Costanzo A, Barcaroli D, et al. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med. 1998; 188: 1763-8.
25. He B, Meng YH, Mivechi NF. Glycogen synthase kinase 3beta and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock. Mol Cell Biol. 1998; 18: 6624-33.
26. Jäättelä M, Wissing D, Kokholm K, et al. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J. 1998; 17: 6124-34.
27. Gottwald E, Muller O, Polten A. Semiquantitative reverse transcription-polymerase chain reaction with the Agilent 2100 Bioanalyzer. Electrophoresis. 2001; 22: 4016-22.
28. Wu G, Osada M, Guo Z, et al. DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res. 2005; 65: 758-66.
29. Ueda Y, Hijikata M, Takagi S, et al. Transcriptional activities of p73 splicing variants are regulated by inter-variant association. Biochem J. 2001; 356: 859-66.
30. Melino G, Bernassola F, Ranalli M, et al. p73 Induces apoptosisviaPUMA transactivation and Bax mitochondrial translocation. J Biol Chem. 2004; 279: 8076-83.
31. Bidere N, Lorenzo HK, Carmona S, et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem. 2003; 278: 31401-11.
32. Feldstein AE, Werneburg NW, Li Z, et al. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G1339-46.
33. Oberle C, Huai J, Reinheckel T, et al. Lysosomal membrane permeabilization and cathepsin release is a Bax/Bak-dependent, amplifying event of apoptosis in fibroblasts and monocytes. Cell Death Differ. 17: 1167-78.
34. Fehrenbacher N, Bastholm L, Kirkegaard-Sorensen T, et al. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res. 2008; 68: 6623-33.
35. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008; 27: 6434-51.
36. Zhu J, Jiang J, Zhou W, et al. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 1998; 58: 5061-5.
37. Lee CW, La Thangue NB. Promoter specificity and stability control of the p53-related protein p73. Oncogene. 1999; 18: 4171-81.
38. Zheng X, Chen X. Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family. FEBS Lett. 2001; 489: 4-7.
39. Blint E, Phillips AC, Kozlov S, et al. Induction of p57(KIP2) expression by p73beta. Proc Natl Acad Sci USA. 2002; 99: 3529-34.
40. Vlachos P, Nyman U, Hajji N, et al. The cell cycle inhibitor p57(Kip2) promotes cell deathviathe mitochondrial apoptotic pathway. Cell Death Differ. 2007; 14: 1497-507.
41. Li CY, Zhu J, Wang JY. Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation. J Biol Chem. 2005; 280: 2159-64.
42. Minty A, Dumont X, Kaghad M, et al. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem. 2000; 275: 36316-23.
43. Ozaki T, Watanabe K, Nakagawa T, et al. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. Oncogene. 2003; 22: 3231-42.
44. Calvaruso G, Giuliano M, Portanova P, et al. Hsp72 controls bortezomib-induced HepG2 cell deathviainteraction with pro-apoptotic factors. Oncol Rep. 2007; 18: 447-50.
45. Jaattela M. Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer. 1995; 60: 689-93.
46. Volloch VZ, Sherman MY. Oncogenic potential of Hsp72. Oncogene. 1999; 18: 3648-51.
47. Samali A, Cotter TG. Heat shock proteins increase resistance to apoptosis. Exp Cell Res. 1996; 223: 163-70.
48. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif. 2000; 33: 341-65.
49. Nylandsted J, Rohde M, Brand K, et al. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA. 2000; 97: 7871-6.
50. Ekedahl J, Joseph B, Marchetti P, et al. Heat shock protein 72 does not modulate ionizing radiation-induced apoptosis in U1810 non-small cell lung carcinoma cells. Cancer Biol Ther. 2003; 2: 663-9.
51. Lanneau D, Brunet M, Frisan E, et al. Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med. 2008; 12: 743-61.
52. Yaglom JA, Gabai VL, Sherman MY. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res. 2007; 67: 2373-81.
53. Nylandsted J, Wick W, Hirt UA, et al. Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res. 2002; 62: 7139-42.